P
Provepharm
Truly unique life sciences research and pharma company, dedicated to a new era of discovery
About Provepharm
Provepharm Life Solutions is a pharmaceutical company specializing in the development and commercialization of injectable solutions. The company primarily serves healthcare providers, hospitals, and clinics across Europe, the United States, and Australia. Provepharm operates in the pharmaceutical market, focusing on niche therapeutic areas where it can provide high-value solutions. The business model revolves around the research, development, and sale of proprietary injectable medications, including methylene blue and various vitamin solutions. Revenue is generated through the direct sale of these products to healthcare institutions and through strategic partnerships. Provepharm's commitment to quality and innovation ensures that its products meet stringent regulatory standards, thereby enhancing patient care and safety.
Source: Dealroom company dataAt a glance
- Founded
- 1998
- Headquarters
- Marseille, France
- Sector
- Biotech & Life Sciences
- Power Law
- Colt$25–100M revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
ACG Management
Région Sud Investissement
Series B and later4 investors entered at this stage
BNP Paribas
Societe Generale
Crédit Agricole
Tikehau Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about Provepharm on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Provepharm on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.